H1N1 vaccine News
Cadila Healthcare: On a booster dose Growth in the domestic formulations segment and robust performance in other geographies boost outlook. Strong domestic performance, coupled with impressive growth in the US, helped Cadila Healthcare post revenue growth of 18.1 per cent year-on-year at Rs 1,117 crore in the September quarter.Booked profits? Be careful about re-entering Cardio-vascular and respiratory care segment buoyed domestic revenues
H1N1 vaccine Galleries
|
|